ABSTRACT To explore the mechanism of increased collagen synthesis by scleroderma skin fibroblasts in vitro, control and scleroderma fibroblasts were compared in confluent monolayer cultures growth-arrested by serum deprivation; responses to optimal mitogenic doses of platelet-derived growth factor, fibroblast growth factor, epidermal growth factor and nerve growth factor were compared. Plateletderived growth factor had a selective mitogenic effect on control skdn fibroblasts not observed with scleroderma skin fibroblasts. None of the factors studied had a selective effect on collagen synthesis independent of cell replication; scleroderma and control fibroblasts responded similarly. Therefore, the growth factors studied may not be involved in generating the activated scleroderma fibroblast directly; platelet-derived growth factor may play an indirect role in fibroblast replication in human fibrotic disorders.
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More than a decade ago, it was observed that fibroblasts from involved skin of patients with scleroderma synthesized increased levels of collagen in vitro (1, 2) ; today the mechanism remains unknown (3) (4) (5) (6) . During this period, observations ofthe pathogenesis of scleroderma have focused on vascular and microvascular lesions; on evidence of endothelial damage; on platelet adhesion, aggregation, and release; and on the subsequent activation both of smooth muscle cells to produce the intimal proliferation and of interstitial fibroblasts to produce fibrosis (7) (8) (9) (10) . A unifying hypothesis would propose the presence offactors released from plasma or platelets which act as stimuli to fibrosis; among such factors, the potent mitogen, plateletderived growth factor (PDGF), is released during endothelial injury and platelet adhesion to the subendothelium (11) . Therefore, the influence of PDGF on skin fibroblast collagen synthesis was studied.
Endothelial damage and platelet interaction with the exposed subendothelium, resulting in release of platelet-derived mitogenic factors (including PDGF), have been proposed, at least indirectly, to play a role in the evolution of the scleroderma vascular lesion. Events preceding endothelial injury are poorly understood; altered immunity leading to humoral or lymphocyte/monocyte mediators ofinjury has been proposed with supporting evidence (12) . If PDGF is the direct mediator of fibroblast activation in scleroderma, the enhanced collagen synthesis of scleroderma fibroblasts should be accompanied by increased cell replication at some stage in the process. Thus, a PDGF mechanism in scleroderma would imply replication offibroblast populations instead of, or in addition to, the selective stimulation ofcollagen synthesis per cell; in earlier studies, increased collagen synthesis per cell was observed in vitro without evidence of increased cell replication (1, 2) . If PDGF is the mediator of fibroblast activation in scleroderma, its action should account for the initial observations of increased collagen synthesis per cell.
A second characteristic of scleroderma fibroblasts in culture has been their insensitivity (of cell replication) to alterations in feeding schedules. This could be interpreted as an insensitivity to PDGF resulting from prior exposure to and maximal stimulation by this serum mitogen in vivo. If this were the case, scleroderma fibroblasts should be relatively insensitive to PDGF when compared with control fibroblasts in vitro.
In order to examine these possibilities, a systematic study of the effects of PDGF on cell replication and collagen synthesis by control and scleroderma fibroblasts was undertaken. Results demonstrate that PDGF has a selective proliferative effect on control fibroblasts, not observed with scleroderma fibroblasts and no selective effect on collagen synthesis. Thus, to be a stimulus for fibroblast activation in scleroderma, PDGF must mediate this activation by its mitogenic action. Similar studies with epidermal growth factor (EGF), fibroblast growth factor (FGF), and nerve growth factor (NGF) are reported herein.
MATERIALS AND METHODS
Skin Biopsies. Two full-thickness skin biopsy specimens (dermis and hypodermis; 4-mm punch) were obtained from the dorsum of the forearm of five scleroderma patients within 3 yr of diagnosis and within 5 yr of the onset of Raynaud's symptoms. All patients had extensive cutaneous and multiple visceral involvement; at the time of biopsy, no patient had organ insufficiency and no patient was receiving medication known to affect connective tissue metabolism. One biopsy was sent for histologic confirmation of scleroderma skin involvement. A healthy donor matched for age, race, and sex of each scleroderma patient underwent a biopsy at an identical site, also histologically confirmed as normal. Each biopsy was placed in medium (containing penicillin and gentamycin) and divided into pieces of 0.5-1 mm3 each. An X was cut into the bottom of a 60-mm culture dish (Falcon Products, Bio Quest, Cockeysville, NY), the biopsy section was placed at its center, 2 Medical Sciences: LeRoy et aL PDGF at 3 units/ml, which corresponds to the optimal proliferative dose in the supplier's hands, using 3T3 cells at confluence. Similar experiments with a scleroderma cell line indicated the same optimal cell density and optimal PDGF concentration. Experiments with FGF, EFG, and NGF (Collaborative Research, Waltham, MA) were performed using concentrations optimal for proliferation as determined by similar techniques. Collagen Assay. The method used was a modification of the collagenase procedure described by Peterkofsky and Diegelmann (18) . Cells were exposed to [3H]proline and harvested, protein from cells and media were precipitated together with trichloroacetic acid and redissolved in 0.2 M NaOH, and duplicate aliquots were incubated with no enzyme (for spontaneously released 3H), protease-free collagenase.(for [3H]collagen), or Pronase [for 3H-labeled total protein (3H-protein)]. Digestions were stopped by trichloroacetic acid precipitation, and supernatants were assayed by scintillation spectrometry. Collagen and total protein synthesis were estimated by subtracting spontaneously-released 3H dpm from collagenase-released 3H dpm and from Pronase-released 3H dpm, respectively; an empirical formula was used to correlate data from the modified procedure (use of Pronase) with those produced by the original method; technical details and validity of the modification have been published (19) .
RESULTS
Cell Viability. Preliminary experiments to compare viability and growth characteristics of the cell strains revealed no differences in cell loss between control and scleroderma cells of the same pair after initial trypsinization and resuspension (2 X 104 cells per cm2 in F12K/0.5 medium); different pairs studied at different times showed losses between 15% and 50% of the cells planted; neonatal foreskin fibroblasts tested similarly showed no loss. At 24 hr, cell counts revealed losses of30-49%, with no differences between control and scleroderma partners of the same pair. At 72 hr, control cells in F12K/0.5 medium were reduced by 0-30%; scleroderma cells remained unchanged from 24-hr cell counts. Initial losses were due to cells failing to adhere to the coated plastic surface. These data further demonstrate the relative stability of scleroderma fibroblasts in vitro and the difficulty in maintaining control adult human fibroblasts at the low serum concentrations necessary to study mitogenic factors.
Replicative responses to growth factors are shown in Table  1 . Results are presented as percentages of low-serum controls to permit comparisons between different experiments. PDGF stimulated control skin fibroblasts more than it did scleroderma fibroblasts and more than other growth factors or serum stimulated control fibroblasts. Scleroderma cells were insensitive to added PDGF, suggesting that they may have been exposed to this mitogen in vivo. In this experimental setting, FGF, EGF, and NGF, which were mitogenic for human newborn foreskin fibroblasts, did not stimulate either control or scleroderma adult skin fibroblasts to replicate, suggesting that mature fibroblasts may lose their capacity to respond to these specialized growth factors.
Figs. 3 A and B present a representative experiment comparing collagen and protein synthesis in F12K/15 medium, F12K/0.5 medium, and F12K/0.5 medium with PDGF by control and scleroderma fibroblasts. In F12K/0.5 medium containing PDGF, levels of collagen and protein synthesis were consistently below those in F12K/15 medium, suggesting that PDGF is not a selective stimulus for collagen or protein synthesis in this system (see Table 1 ). Also, there was no detectable difference between the effect of PDGF on control or scleroderma fibroblasts, suggesting that prior exposure to PDGF is not the basis for increased collagen synthesis by scleroderma fibroblasts. Thus, the precise stimulus or stimuli for fibroblast activation in scleroderma remains unknown. When normalscleroderma pairs were compared, dpm of [3H]collagen per cell and percentage collagen per cell were greater in scleroderma cells in all conditions tested (P < 0.001; Fig. 3A) , an observation repeatedly confirmed in the literature (1, 2, 4-6) .
Similar studies were conducted with FGF, EGF, and NGF. As shown in Table 2 , growth factors in the presence of low serum (F12K/0.5 medium) did not selectively stimulate either collagen or protein synthesis when corrected for cell replication and compared with the effect ofF12K/15 (high serum) or F12K/ 0.5 (low serum). Moreover, in no case except NGF did growth factors (in low serum) equal or exceed the stimulation observed with high serum. Results with NGF seemed to show equal or slightly greater stimulation with scleroderma than with control (20) or by nonspecific mitogens (21, 22) , leads to the elaboration of soluble factors, still poorly identified, which modulate fibroblast proliferation and collagen synthesis. The precise role of these immune events in the pathogenesis of scleroderma awaits further investigation.
Associated with this early monocyte accumulation is a distinctive injury of the vascular endothelium that may be mediated by a serum activity selectively cytotoxic to endothelial cells in vitro (23, 24) . A damaged endothelium allows release of vascular-derived factors to stimulate interstitial fibroblasts to replicate, synthesize collagen, and produce fibrosis. The present work explores the effects of the powerful serum mitogen for smooth muscle cells and fibroblasts, PDGF, which is released from the platelet a granule on the interaction ofthe blood platelet with the subendothelium of a damaged blood vessel. Such interaction involves adhesion, aggregation, and release ofplatelet granule constituents (25) . Under the conditions of the present study, PDGF was selectively mitogenic for control fibroblasts, was not mitogenic for scleroderma fibroblasts, and did not selectively stimulate fibroblast collagen or protein synthesis.
Central to defining the precise mechanism of fibrosis in scleroderma is an understanding of the role of proliferation or replication of fibroblasts in this and other human fibrotic disorders. Directed migration by fibroblast chemotaxis also must be considered (26) . Proliferation of fibroblasts may contribute to fibrosis both by increased number of cells-all producing equivalent amounts of connective tissue-and by the selection of fibroblasts after multiple population doublings, which inherently produce large quantities of collagen (27) . The process offibroblast replication has been viewed as differentiation (28) . Most in vitro studies of fibroblast behavior vis-a-vis fibrosis have focused on collagen or proteoglycan synthesis and have not assessed the relationship of cell replication to the synthesis and assembly of extracellular matrix. Whether a specific linkage exists between fibroblast replication and phenotypic expression (collagen synthesis)-for example, in lymphocyte subsets, where replication and lymphokine production are closely associated (29)-remains unknown. PDGF has been shown to be a necessary but not sufficient mitogen for fibroblasts in vitro and shares a cooperative role with somatomedins for full mitogenic expression (17) . In the present study, no evidence could be found for a selective role of PDGF on collagen synthesis in control or scleroderma fibroblasts. Nonetheless, the selective mitogenic effect of PDGF on control fibroblasts and the insensitivity to PDGF of fibroblasts from scleroderma subjects suggests that scleroderma fibroblasts may have been altered by PDGF exposure in vivo.
The growth factors reported in this study showed no effect on collagen synthesis over and above their effect on fibroblast replication. In this regard a caveat is suggested: for any biological or pharmacologic agent to be shown to have a direct effect on fibroblast collagen synthesis, it should be clearly demonstrated that the observed effect is not produced by mitogenesis. This caveat should apply to matrix components (NH2-terminal procollagen peptides), to sympathetic neurotransmitters (,8-adrenergic agonists and antagonists), to inflammatory mediators (prostaglandins, serotonin, histamine), or to drugs (bleomycin). A possible common effector for all ofthese agents could be cyclic AMP, whose effect on collagen synthesis may be secondary to a replicative effect. A large number of studies (1, 2, 30) have not been well controlled for effects on cell replication. The use of cell counts, cell DNA, or cell protein as denominators may not reflect mitogenic signals unless sufficient time elapses for completed cell replication.
The regulation of fibrosis and collagen synthesis in developmental and pathological settings is not understood. In pathologic states, fibrosis often follows inflammatory and granulomatous responses. The increasing knowledge ofthe role ofthe blood platelet in inflammation led us to study PDGF as a possible stimulus of fibrosis in scleroderma. Scleroderma fibroblasts demonstrated an insensitivity to PDGF in these studies. Further study is needed to determine whether inflammation generates specific signals that stimulate collagen synthesis in resident fibroblasts or whether fibroblast populations are attracted to or selected by replication for the initiation offibrosis.
